David Westerman
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 59
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 44
- Hematology top 1%
- Acute Myeloid Leukemia Research 21
- Chronic Myeloid Leukemia Treatments 14
- Oncology top 5%
- Viral-associated cancers and disorders 12
- Dermatology top 2%
-
- Acute Lymphoblastic Leukemia research 14
-
- Immunodeficiency and Autoimmune Disorders 11
- Co-authors
- John F. SeymourConstantine S. TamH. Miles PrinceAndrew W. RobertsMary Ann AndersonPiers BlomberyStephen LadeDavid C.S. Huang
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
David Westerman
120 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Genetics 1.4k
- Pathology and Forensic Medicine 1.4k
- Hematology 732
- Oncology 776
- Dermatology 241
Countries citing papers authored by David Westerman
This map shows the geographic impact of David Westerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Westerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Westerman more than expected).
Fields of papers citing papers by David Westerman
This network shows the impact of papers produced by David Westerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Westerman. The network helps show where David Westerman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Westerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 17 | |
| 5 | 2020 | 31 | |
| 6 | Characteristics and Outcomes of Therapy-Related Myeloid Neoplasms after Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Neoplasm (NEN): A Single Centre Series | 2019 | 2 |
| 7 | Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemiabreakdown → | 2018 | 276 |
| 8 | 2017 | 14 | |
| 9 | 2016 | 215 | |
| 10 | The combination of ibrutinib and venetoclax (ABT-199) rapidly achieves complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study | 2016 | 3 |
| 11 | 2014 | 15 | |
| 12 | 2013 | 50 | |
| 13 | 2011 | 52 | |
| 14 | 2010 | 12 | |
| 15 | FLUDARABINE BASED COMBINATION THERAPY IS HIGHLY ACTIVE AS PRIMARY OR SALVAGE TREATMENT IN PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA | 2009 | 1 |
| 16 | RAPID INFUSION OF RITUXIMAB IS WELL TOLERATED AND ENABLES MORE EFFICIENT USE OF HAEMATOLOGY DAY WARD RESOURCES | 2009 | 2 |
| 17 | 2005 | 8 | |
| 18 | 2005 | 20 | |
| 19 | 2000 | 2 | |
| 20 | 1999 | 19 |
About David Westerman
David Westerman is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 125 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (59 papers), Lymphoma Diagnosis and Treatment (44 papers), Acute Myeloid Leukemia Research (21 papers), Chronic Myeloid Leukemia Treatments (14 papers), Acute Lymphoblastic Leukemia research (14 papers), Viral-associated cancers and disorders (12 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). The work is most often cited by research in Genetics (1.4k citations), Pathology and Forensic Medicine (1.4k citations) and Hematology (732 citations). David Westerman has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include John F. Seymour, Constantine S. Tam, H. Miles Prince, Andrew W. Roberts, Mary Ann Anderson, Piers Blombery, Stephen Lade, David C.S. Huang, Dennis Carney and David Ritchie. Their work appears in journals such as Blood, British Journal of Haematology, Cancer, Blood Advances and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.